National breast and ovarian cancer centre breast diseases. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Breast Cell Line, Tumor Nipples Tumor Cells, Cultured MCF-7 Cells Body Fluids Axilla Mammary Glands, Human Lymph Nodes Milk, Human Epithelial Cells Neoplastic Stem Cells Ovary

Organisms2

Mice, Nude Mice, SCID

Diseases55

Breast Diseases Fibrocystic Breast Disease Breast Neoplasms Ovarian Neoplasms Carcinoma, Ductal, Breast Uterine Cervical Neoplasms Fibroadenoma Adenofibroma Neoplasms, Glandular and Epithelial Carcinoma, Intraductal, Noninfiltrating Neoplasm Invasiveness Carcinoma Neoplasms Hyperplasia Neoplasm Metastasis Breast Cyst Carcinoma in Situ Carcinoma, Lobular Precancerous Conditions Breast Neoplasms, Male Cystadenocarcinoma, Serous Neoplasm Recurrence, Local Disease Progression Genetic Predisposition to Disease Lung Neoplasms Lymphatic Metastasis Mastitis Prostatic Neoplasms Cell Transformation, Neoplastic Adenocarcinoma, Clear Cell Adenocarcinoma, Mucinous Adenocarcinoma Peritoneal Neoplasms Colonic Neoplasms Stomach Neoplasms Carcinoma, Endometrioid Neoplasms, Second Primary Neoplasms, Hormone-Dependent Mammary Neoplasms, Experimental Ascites Pancreatic Neoplasms Colorectal Neoplasms Bone Neoplasms Endometrial Neoplasms Genital Neoplasms, Female Carcinoma, Squamous Cell Hereditary Breast and Ovarian Cancer Syndrome Neoplasms, Multiple Primary Neovascularization, Pathologic Cystadenocarcinoma Carcinoma, Ductal Triple Negative Breast Neoplasms Carcinoma, Non-Small-Cell Lung Fallopian Tube Neoplasms Inflammatory Breast Neoplasms

Chemicals and Drugs42

Tumor Markers, Biological Receptors, Estrogen Receptors, Progesterone Antineoplastic Agents Receptor, erbB-2 CA-125 Antigen Neoplasm Proteins Tamoxifen BRCA2 Protein BRCA1 Protein Estrogens Cisplatin Antineoplastic Agents, Hormonal RNA, Messenger Paclitaxel Antigens, Neoplasm Antibodies, Monoclonal DNA, Neoplasm Antineoplastic Agents, Phytogenic RNA, Small Interfering Estrogen Receptor alpha Progestins Taxoids Carboplatin Cathepsin D Tumor Suppressor Protein p53 Fluorouracil Cyclophosphamide Antibodies, Monoclonal, Humanized Prostate-Specific Antigen RNA, Neoplasm Estrogen Antagonists Cancer Vaccines Tumor Suppressor Proteins Aromatase Inhibitors Epididymal Secretory Proteins Transcription Factors Receptor, Epidermal Growth Factor Estradiol Mucin-1 Ki-67 Antigen DNA-Binding Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment76

Mammography Mass Screening Early Detection of Cancer Risk Factors Prognosis Neoplasm Staging Retrospective Studies Case-Control Studies Prospective Studies Mastectomy Risk Follow-Up Studies Survival Analysis Biopsy Immunohistochemistry Biopsy, Needle Cohort Studies Risk Assessment Survival Rate Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Odds Ratio Ultrasonography, Mammary Incidence Disease-Free Survival Sensitivity and Specificity Multivariate Analysis Questionnaires Chemotherapy, Adjuvant Breast Self-Examination Logistic Models Breast Implants Proportional Hazards Models Confidence Intervals Registries Palpation Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Predictive Value of Tests Kaplan-Meier Estimate Xenograft Model Antitumor Assays Mastectomy, Segmental Immunoenzyme Techniques Estrogen Replacement Therapy Reproducibility of Results Genetic Testing Blotting, Western Combined Modality Therapy Clinical Trials as Topic Neoplasm Transplantation Mammaplasty Neoplasm Grading Palliative Care Oligonucleotide Array Sequence Analysis Mammary Neoplasms, Experimental Transplantation, Heterologous Tissue Array Analysis Radiotherapy, Adjuvant Drug Administration Schedule Polymerase Chain Reaction Tumor Burden SEER Program Drug Screening Assays, Antitumor Transfection Lymph Node Excision Radiotherapy Prevalence Cross-Sectional Studies Pilot Projects DNA Mutational Analysis Feasibility Studies Clinical Trials, Phase I as Topic Neoadjuvant Therapy Breast Implantation Regression Analysis Gene Knockdown Techniques

Psychiatry and Psychology4

Breast Feeding Breast Self-Examination Smoking Alcohol Drinking

Phenomena and Processes43

Breast Feeding Menopause Genes, BRCA1 Gene Expression Regulation, Neoplastic Risk Odds Ratio Time Factors Drug Resistance, Neoplasm Genes, BRCA2 Postmenopause Sensitivity and Specificity Genetic Predisposition to Disease Cell Proliferation Premenopause Parity Mutation Germ-Line Mutation Apoptosis Menarche Menstruation Signal Transduction Genotype Cell Movement Cell Division DNA Methylation Pregnancy Dose-Response Relationship, Drug Genes, erbB-2 Down-Regulation Polymorphism, Genetic Cell Growth Processes Transfection Promoter Regions, Genetic Up-Regulation Cell Cycle Genes, Tumor Suppressor RNA Interference Base Sequence Heterozygote Gene Silencing Gene Expression Gene Amplification Phenotype

Disciplines and Occupations4

Immunohistochemistry Medical Oncology Oncology Nursing Genetic Counseling

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)National Institutes of Health (U.S.)Quality of Life

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science8

Survival Rate Incidence Questionnaires Registries SEER Program Prevalence Molecular Sequence Data Base Sequence

Named Groups4

Medically Uninsured Survivors European Continental Ancestry Group African Americans

Health Care46

Mass Screening Cancer Care Facilities Risk Factors Retrospective Studies Case-Control Studies National Cancer Institute (U.S.)Prospective Studies Age Factors Risk Follow-Up Studies Survival Analysis Cohort Studies Risk Assessment Survival Rate Treatment Outcome Odds Ratio Incidence Disease-Free Survival Sensitivity and Specificity Multivariate Analysis Questionnaires National Institutes of Health (U.S.)Parity Logistic Models Proportional Hazards Models Oncology Service, Hospital Confidence Intervals Registries Predictive Value of Tests Kaplan-Meier Estimate Reproducibility of Results Genetic Testing Family Health Clinical Trials as Topic Palliative Care National Health Programs SEER Program Oncology Nursing Prevalence Cross-Sectional Studies Pilot Projects Outpatient Clinics, Hospital Feasibility Studies Clinical Trials, Phase I as Topic Genetic Counseling Regression Analysis

Geographicals7

Canada United States China Texas Japan Delaware England

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Breast Diseases Fibrocystic Breast Disease Mammography Breast Breast Neoplasms Mass Screening Ovarian Neoplasms Early Detection of Cancer Medically Uninsured Canada Cancer Care Facilities Carcinoma, Ductal, Breast United States Uterine Cervical Neoplasms Fibroadenoma Adenofibroma Neoplasms, Glandular and Epithelial Risk Factors Carcinoma, Intraductal, Noninfiltrating Prognosis Cell Line, Tumor Tumor Markers, Biological Neoplasm Invasiveness Receptors, Estrogen Neoplasm Staging Carcinoma Retrospective Studies Breast Feeding Menopause Case-Control Studies Neoplasms Hyperplasia Genes, BRCA1 Gene Expression Regulation, Neoplastic National Cancer Institute (U.S.)Neoplasm Metastasis Nipples Breast Cyst Carcinoma in Situ Receptors, Progesterone Carcinoma, Lobular Prospective Studies Mastectomy Antineoplastic Agents Age Factors Precancerous Conditions Breast Neoplasms, Male Risk Receptor, erbB-2 Follow-Up Studies CA-125 Antigen Neoplasm Proteins Survival Analysis Biopsy Immunohistochemistry Biopsy, Needle Cystadenocarcinoma, Serous Cohort Studies Risk Assessment Survival Rate Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Odds Ratio Ultrasonography, Mammary Incidence Time Factors Tamoxifen Drug Resistance, Neoplasm Disease-Free Survival Genes, BRCA2 Neoplasm Recurrence, Local Postmenopause Mice, Nude BRCA2 Protein Sensitivity and Specificity BRCA1 Protein Estrogens Disease Progression Genetic Predisposition to Disease Multivariate Analysis Cell Proliferation Questionnaires Medical Oncology National Institutes of Health (U.S.)Tumor Cells, Cultured Chemotherapy, Adjuvant Premenopause Parity Breast Self-Examination Lung Neoplasms Logistic Models Lymphatic Metastasis Breast Implants Proportional Hazards Models Oncology Service, Hospital Confidence Intervals Mastitis Registries Prostatic Neoplasms Cisplatin

No FAQ available that match "national breast and ovarian cancer centre breast diseases"